Skip to main content

Australian Program for Drug Repurposing for Treatment Resistant Ovarian Cancer Treatment

Project Member(s): Marsh, D.

Funding or Partner Organisation: Medical Research Future Fund (MRFF - Ovarian Cancer Research)
Medical Research Future Fund (MRFF - Ovarian Cancer Research)

Start year: 2020


Xie, T, Dickson, K-A, Yee, C, Ma, Y, Ford, CE, Bowden, NA & Marsh, DJ 2022, 'Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival', Cancers, vol. 14, no. 19, pp. 4621-4621.
View/Download from: Publisher's site

Yee, C, Dickson, K-A, Muntasir, MN, Ma, Y & Marsh, DJ 2022, 'Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine', Frontiers in Bioengineering and Biotechnology, vol. 10.
View/Download from: Publisher's site

FOR Codes: Health, Medical And Health Sciences, Biological Sciences, Cancer therapy (excl. chemotherapy and radiation therapy), Basic pharmacology